2024-01-012024-12-312024-12-31false10283353CIRCADIAN THERAPEUTICS LIMITED2025-01-2986900falseiso4217:GBPxbrli:pure102833532024-01-01102833532024-12-31102833532024-01-012024-12-31102833532023-01-01102833532023-12-31102833532023-01-012023-12-3110283353bus:Micro-entities2024-01-012024-12-3110283353bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3110283353bus:FullAccounts2024-01-012024-12-3110283353bus:PrivateLimitedCompanyLtd2024-01-012024-12-3110283353core:WithinOneYear2024-12-3110283353core:AfterOneYear2024-12-3110283353core:WithinOneYear2023-12-3110283353core:AfterOneYear2023-12-3110283353dpl:CostSales2024-01-012024-12-3110283353dpl:AdministrativeExpenses2024-01-012024-12-3110283353dpl:DistributionCosts2024-01-012024-12-3110283353dpl:CostSales2023-01-012023-12-3110283353dpl:AdministrativeExpenses2023-01-012023-12-3110283353dpl:DistributionCosts2023-01-012023-12-3110283353core:WithinOneYear2024-12-3110283353core:AfterOneYear2024-12-3110283353core:WithinOneYear2023-12-3110283353core:AfterOneYear2023-12-3110283353core:WithinOneYear2024-01-012024-12-3110283353core:AfterOneYear2024-01-012024-12-3110283353bus:Director12024-01-012024-12-3110283353bus:Director22024-01-012024-12-3110283353bus:Director32024-01-012024-12-3110283353bus:Director42024-01-012024-12-3110283353bus:Director52024-01-012024-12-31

CIRCADIAN THERAPEUTICS LIMITED

Registered Number
10283353
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

CIRCADIAN THERAPEUTICS LIMITED
Company Information
for the year from 1 January 2024 to 31 December 2024

Directors

DIXON-CLEGG, Nicholas George
FOSTER, Russell
JONES, Julia Frances
SNAPE, Michael Frederick, Dr
WALLACE, Wallace Lucy Elizabeth

Registered Address

46 Woodstock Road
Oxford
OX2 6HT

Registered Number

10283353 (England and Wales)
CIRCADIAN THERAPEUTICS LIMITED
Balance Sheet as at
31 December 2024

2024
£

2023
£

Assets
Fixed Assets1,5792,440
Current Assets156,179165,180
Prepayments and accrued income8,2178,657
165,975176,277
Capital, Reserves and Liabilities
Capital and reserves(2,529,825)(2,381,781)
Creditors amounts falling due within one year2,678,5702,542,066
Accruals and deferred income17,23015,992
165,975176,277
The financial statements were approved and authorised for issue by the Board of Directors on 29 January 2025, and are signed on its behalf by:
SNAPE, Michael Frederick, Dr
Director
Registered Company No. 10283353